Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
32 hedge funds and large institutions have $14.1M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
23% more capital invested
Capital invested by funds: $11.5M → $14.1M (+$2.65M)
14% more funds holding
Funds holding: 28 → 32 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$1.66M |
| 2 |
Walleye Trading
New York
|
+$217K |
| 3 |
Renaissance Technologies
New York
|
+$119K |
| 4 |
CC
Clearline Capital
New York
|
+$71.3K |
| 5 |
JP Morgan Chase
New York
|
+$59.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$1.31M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$345K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$35.8K |
| 4 |
Morgan Stanley
New York
|
-$422 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Dimensional Fund Advisors
Austin,
Texas
| $16K | – | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $7K | +$3.37K | +8 | +100% |
|
|
WEC
28
Winslow Evans & Crocker
Boston,
Massachusetts
| $2K | – | – | – |
|
|
29
Morgan Stanley
New York
| $1K | -$422 | -1 | -20% |
|
|
PCM
30
Princeton Capital Management
Red Bank,
New Jersey
| $1K | – | – | – |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| $1K | +$843 | +2 | New |
|
|
PA
32
Perceptive Advisors
New York
| – | -$1.31M | -3,628 | Closed |
|
|
EAM
33
Eventide Asset Management
Boston,
Massachusetts
| – | -$345K | -952 | Closed |
|
FRTX Hedge Fund Activity: Q3 2018 in Review
32 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q3 2018, worth a combined $14.1M — up 23% from $11.5M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new FRTX positions and 3 closed out — a net gain of 4 holders — while 9 added to existing stakes and 2 trimmed.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $1.66M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.31M sold.
- 32 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q3 2018, up from 28 in Q2 2018.
- Funds reported $14.1M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q3 2018, up 23% quarter-over-quarter.
- 7 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q3 2018 and 3 closed out, a net change of +4 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q3 2018 was Sio Capital Management, an estimated $1.66M added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q3 2018 was Perceptive Advisors, an estimated $1.31M sold.
Based on aggregated 13F filings for Q3 2018.